CSTL ▼ -0.3% - Castle Biosciences, Inc.
$CSTL CSTL - New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™
24-SEP-2026 04:30 PM ET
Share this post
More filings for $CSTL
CSTL - Castle Biosciences, Inc. - SEC Filing Update (29-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 29, 2026CSTL ▼ -0.1% - Castle Biosciences, Inc.Oct 28, 2026CSTL ▲ +0.5% - Castle Biosciences, Inc.Oct 15, 2026CSTL ▼ -5.0% - Castle Biosciences, Inc.Oct 12, 2026CSTL ▲ +1.9% - Castle Biosciences, Inc.Sep 30, 2026CSTL ▼ -0.1% - Castle Biosciences, Inc.Sep 28, 2026
View full $CSTL filing history →💬 Comments
Loading comments…
Leave a comment